NEW YORK (GenomeWeb) – BG Medicine said today that it has amended its agreement with Abbott Laboratories for licensing and distributing its galectin-3 test.

The amendment changes product fees Abbott pays to BG Medicine for galectin-3 tests it sells to reference laboratories. In addition, Abbott was to make a payment of $500,000 to BG Medicine by November 30 and will make another $500,000 payment by June 30, 2016, provided certain commercial milestones are met.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.